TREATING PROSTATE CANCER AT ANY STAGE.

ANDROGEN receptors; PROSTATE cancer; MALE reproductive organs; PROSTATE cancer patients; LYMPHADENECTOMY; POSITRON emission tomography computed tomography; PELVIS

New technology and improved treatment protocols are leading to better outcomes for patients with prostate cancer. The controversy surrounding prostate-specific antigen (PSA) testing continues, but advancements in understanding the growth of certain prostate cancers have improved patient prognoses at every stage of the disease. Prostate cancer remains one of the most common cancers among men, but the majority of patients will live for years after diagnosis and are more likely to die from unrelated causes. Advances in diagnostic imaging tests have also transformed the way prostate cancer is approached, allowing for more targeted and effective treatments. [Extracted from the article]

Copyright of Scientific American is the property of Scientific American and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)